Estimation of Abbreviated Mycophenolic Acid Area Under the Concentration-Time Curve During Early Posttransplant Period by Limited Sampling Strategy

Transplantation Proceedings

Volumn 40, Issue 10, 2008, Pages 3668-3672

  Mohammadpour, A H ^a   Nazemian, F ^b   Abtahi, B ^a   Naghibi, M ^b   Gholami, K ^e   Rezaee, S ^c   Nazari, M R A ^d   Rajabi, O ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; MYCOPHENOLIC ACID; PREDNISOLONE;

ADULT; ANTHROPOMETRY; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DEMOGRAPHY; DRUG MONITORING; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; IRAN; KIDNEY FUNCTION; KIDNEY GRAFT; MALE; MULTIPLE REGRESSION; PATIENT INFORMATION; POSTOPERATIVE CARE; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; RISK FACTOR; VALIDATION PROCESS;

ADOLESCENT; ADULT; ANTIBIOTICS, ANTINEOPLASTIC; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CREATININE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; POSTOPERATIVE PERIOD; PREDNISOLONE; SAMPLE SIZE; YOUNG ADULT;

EID: 57549108858     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.08.133     Document Type: Article

References (20)

1. Yeung S., Tong K.L., Tsang W.K., et al. Determination of mycophenolate area under the curve by limited sampling strategy. Transplant Proc 33 (2001) 1052
2. Yeung S., Tong K.L., Tsang W.K., et al. Pharmacokinetic study of mycophenolate mofetil in asian renal transplant recipients. Transplant Proc 32 (2000) 1753
3. Aigrain E.J., Shaghaghi E.K., Baudouin V., et al. Pharmacokinetics of mycophenolate mofetil in eight pediatric renal transplant patients. Transplant Proc 32 (2000) 388
4. Armstrong V.W., Shipkova M., Schütz E., et al. Monitoring of mycophenolic acid in pediatric renal transplant recipients. Transplant Proc 33 (2001) 1040
5. Mourad M., Malaise J., Eddour D.C., et al. Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil. Clin Chem 47 (2001) 88
6. Barbari A., Stephan A., Masri M.A., et al. Mycophenolic acid plasma trough level: correlation with clinical outcome. Exp Clin Transplant 3 (2005) 355
7. Cox V.C., and Enson M.H.H. Mycophenolate mofetil for solid organ transplantation: does the evidence support the need for clinical pharmacokinetic monitoring?. Ther Drug Monit 25 (2003) 137
8. Wollenberg K., Krumme B., Schollmeyer P., et al. Pharmacokinetics of mycophenolic acid after renal transplantation. Transplant Proc 30 (1998) 2237
9. Krumme B., Wollenberg K., Kirste G., et al. Drug monitoring of mycophenolic acid in the early period after renal transplantation. Transplant Proc 30 (1998) 1773
10. Brusa P., Ceruti M., Casullo R., et al. Pharmacokinetic monitoring of mycophenolate mofetil in kidney transplanted patients. IL Farmaco 55 (2000) 270
11. Armstrong V.W., Shipkova M., Schütz E., et al. Monitoring of mycophenolic acid in pediatric renal transplant recipients. Transplant Proc 33 (2001) 1040
12. Pawinski T., Durlik M., Szlaska I., et al. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant. J Clin Pharm Ther 31 (2006) 27
13. Weber L.T., Schutz E., Lamersdorf T., et al. Pharmacokinetic of mycophenolic acid (MPA) and free MPA in pediatric renal transplant recipients-a multi centre study. Nephrol Dial Transplant 14 suppl 4 (1999) 33
14. Filler G., and Mai J. Limited sampling strategy for mycophenolic acid under the curve. Ther Drug Monit 22 (2000) 169
15. Johnson A.G., Rigby R.J., Taylor P.J., et al. The kinetics of mycophenolic acid and its glucuronide metabolite in adult kidney transplant recipients. Clin Pharmacol Ther 66 (1999) 492
16. Van Hest R.M., Mathot R.A.A., Vulto A.G., et al. Mycophenolic acid in diabetic renal transplant recipients: pharmacokinetic and application of a limited sampling strategy. Ther Drug Monit 26 (2004) 620
17. Le Gullec C., Buchel M., Giraudeau B., et al. Stimultance estimation of cyclosporine and mycophenolic acid areas under the curve in stable renal transplant patients using a limited sampling strategy. Eur J Clin Pharmacol 57 (2002) 805
18. Jahnson H.J., Hiem-Duthoy K.L., and Ptachicinski R.J. Renal transplantation. In: DiPiro J.T., Talbert R.L., and Yee G.C. (Eds). Pharmacotherapy a Pathopysiologic Apporoarch. 4th ed. (1999), Appleton & Lange, Stanford, Conn 771
19. Shaw L.W., Kaplan B., DeNofrio D., et al. Pharmacokinetic and concentration-control investigations of mycophenolic acid in adults after transplantation. Ther Drug Monit 22 (2000) 14
20. Baraldo M., Isola M.T., Feruglio A., et al. Theraputic mycophenolic acid monitoring by means of limited sampling startegy in orthotopic heart transplant patients. Transplant Proc 37 (2005) 2240